The XPRIZE Foundation, a nonprofit organization that creates highly coveted prizes for advances in human endeavor, will award a total of $50 million – the biggest XPRIZE yet – to anyone who develops a new therapy for Alzheimer’s.

Though details of the prize have yet to be finalized, it may rally a new set of innovators to the charge against this disease, said Eric Leuthardt, Washington University School of Medicine in St. Louis, Missouri, one of the scientists who proposed the idea at this year’s Visioneering conference, 25-28 April 2013. 

This annual meeting brings together experts from many disciplines to vote on what the XPRIZE Foundation should fund next.

More information at the links below: